As of 2025-09-16, the Intrinsic Value of Pangenomic Health Inc (NARA.CN) is -1.26 CAD. This NARA.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.10 CAD, the upside of Pangenomic Health Inc is -160.15%.
Based on its market price of 2.10 CAD and our intrinsic valuation, Pangenomic Health Inc (NARA.CN) is overvalued by 160.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.26 - -1.26 | -1.26 | -160.15% |
| P/E | 2.10 - 2.10 | 2.10 | -0.2% |
| DDM - Stable | (1.39) - (2.89) | (2.14) | -201.9% |
| DDM - Multi | (1.03) - (1.67) | (1.27) | -160.7% |
| Market Cap (mil) | 29.19 |
| Beta | 2.29 |
| Outstanding shares (mil) | 13.90 |
| Enterprise Value (mil) | 29.16 |
| Market risk premium | 5.10% |
| Cost of Equity | 14.31% |
| Cost of Debt | 5.00% |
| WACC | 13.97% |